Advanced search
Publication Cover
Journal of Asthma and Allergy Volume 12, 2019 - Issue
Submit an article Journal homepage
151
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Characterizing Real-World Use Of Tiotropium In Asthma In The USA

Carlyne M Averell1 US Value Evidence and Outcomes, GlaxoSmithKline, Research Triangle Park, NC, USACorrespondence[email protected]
,
François Laliberté2 Groupe d’analyse, Ltée, Montreal, QC, Canada
,
Mei Sheng Duh3 Analysis Group, Inc, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-5035-6687
ORCID Icon,
Jennifer W Wu2 Groupe d’analyse, Ltée, Montreal, QC, CanadaORCID Iconhttps://orcid.org/0000-0003-2841-7732
ORCID Icon,
Guillaume Germain2 Groupe d’analyse, Ltée, Montreal, QC, Canada
&
Sarai Faison4 US Medical Affairs, GlaxoSmithKline, Research Triangle Park, NC, USAORCID Iconhttps://orcid.org/0000-0003-0240-4394
ORCID Icon
Pages 309-321 | Published online: 07 Oct 2019

References

  • Centers for Disease Control and Prevention. National Current Asthma Prevalence; 2016 Available from: https://www.cdc.gov/asthma/most_recent_data.htm. Accessed 103, 2018.
  • Peters SP, Jones CA, Haselkorn T, Mink DR, Valacer DJ, Weiss ST. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national web-based survey. J Allergy Clin Immunol. 2007;119(6):1454–1461. doi:10.1016/j.jaci.2007.03.02217481716
  • Centers for Disease Control and Prevention. Uncontrolled Asthma among Persons with Current Asthma. Available from: https://www.cdc.gov/asthma/asthma_stats/uncontrolled_asthma.htm. Accessed February, 2018.
  • Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. Respir Med. 2006;100(7):1139–1151. doi:10.1016/j.rmed.2006.03.03116713224
  • Global GINA Strategy for Asthma Management and Prevention; 2018 Available from: http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/. Accessed 3, 2018.
  • US Department of Health and Human Services, National Institutes of Health. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Heart, Lung, and Blood Institute (US); 2007.
  • Wu AC, Butler MG, Li L, et al. Primary adherence to controller medications for asthma is poor. Ann Am Thorac Soc. 2015;12(2):161–166. doi:10.1513/AnnalsATS.201410-459OC25569765
  • Makhinova T, Barner JC, Richards KM, Rascati KL. Asthma controller medication adherence, risk of exacerbation, and use of rescue agents among texas medicaid patients with persistent asthma. J Manag Care Spec Pharm. 2015;21(12):1124–1132. doi:10.18553/jmcp.2015.21.12.112426679962
  • de Llano LP, Sanmartin AP, Gonzalez-Barcala FJ, et al. Assessing adherence to inhaled medication in asthma: impact of once-daily versus twice-daily dosing frequency. The ATAUD study. J Asthma. 2018;55(9):1–6.28463581
  • Williams LK, Joseph CL, Peterson EL, et al. Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence. J Allergy Clin Immunol. 2007;120(5):1153–1159. doi:10.1016/j.jaci.2007.08.02017936894
  • Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med. 2009;180(9):817–822. doi:10.1164/rccm.200902-0166OC19644048
  • Bender BG, Pedan A, Varasteh LT. Adherence and persistence with fluticasone propionate/salmeterol combination therapy. J Allergy Clin Immunol. 2006;118(4):899–904. doi:10.1016/j.jaci.2006.07.00217030244
  • Apter AJ, Boston RC, George M, et al. Modifiable barriers to adherence to inhaled steroids among adults with asthma: it’s not just black and white. J Allergy Clin Immunol. 2003;111(6):1219–1226. doi:10.1067/mai.2003.147912789220
  • Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol. 2004;114(6):1288–1293. doi:10.1016/j.jaci.2004.09.02815577825
  • Dima AL, Hernandez G, Cunillera O, Ferrer M, de Bruin M; Astro-Lab group. Asthma inhaler adherence determinants in adults: systematic review of observational data. Eur Respir J. 2015;45(4):994–1018. doi:10.1183/09031936.0017211425504997
  • Makela MJ, Backer V, Hedegaard M, Larsson K. Adherence to inhaled therapies, health outcomes and costs in patients with asthma and COPD. Respir Med. 2013;107(10):1481–1490. doi:10.1016/j.rmed.2013.04.00523643487
  • Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin North Am. 2005;25(1):107–130. doi:10.1016/j.iac.2004.09.00515579367
  • US Food and Drug Administration. New Drug Application (NDA): 207070 (Spiriva Respimat); 2015 Available from: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207070. Accessed 3, 2018.
  • Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139. doi:10.1097/01.mlr.0000182534.19832.8316224307
  • Kew KM, Dahri K. Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA/ICS) versus LABA/ICS for adults with asthma. Cochrane Database Syst Rev. 2016;1:CD011721.
  • Kerstjens HAM, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy. N Engl J Med. 2012;367(13):1198–1207. doi:10.1056/NEJMoa120860622938706
  • Kerstjens HA, Disse B, Schroder-Babo W, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol. 2011;128(2):308–314. doi:10.1016/j.jaci.2011.04.03921636120

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.